Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Current Taxes (2020 - 2022)

Historic Current Taxes for Mereo BioPharma (MREO) over the last 3 years, with Q2 2022 value amounting to -$1.9 million.

  • Mereo BioPharma's Current Taxes fell 21635.02% to -$1.9 million in Q2 2022 from the same period last year, while for Jun 2022 it was -$1.9 million, marking a year-over-year decrease of 21635.02%. This contributed to the annual value of $2.1 million for FY2021, which is 4338.44% down from last year.
  • Mereo BioPharma's Current Taxes amounted to -$1.9 million in Q2 2022, which was down 21635.02% from $2.1 million recorded in Q4 2021.
  • Mereo BioPharma's Current Taxes' 5-year high stood at $3.7 million during Q4 2020, with a 5-year trough of -$1.9 million in Q2 2022.
  • For the 3-year period, Mereo BioPharma's Current Taxes averaged around $1.5 million, with its median value being $1.8 million (2020).
  • Per our database at Business Quant, Mereo BioPharma's Current Taxes crashed by 1006.87% in 2021 and then crashed by 21635.02% in 2022.
  • Quarter analysis of 3 years shows Mereo BioPharma's Current Taxes stood at $3.7 million in 2020, then crashed by 44.94% to $2.1 million in 2021, then plummeted by 193.85% to -$1.9 million in 2022.
  • Its Current Taxes was -$1.9 million in Q2 2022, compared to $2.1 million in Q4 2021 and $1.7 million in Q2 2021.